1. US Preventive Services Task Force, Bibbins-Domingo K, Grossman DC, Curry SJ, Barry MJ, Davidson KW, et al. Screening for preeclampsia: US preventive services task force recommendation statement. JAMA 2017; 317: 1661-1667. https://doi.org/10.1001/jama.2017.4011 https://doi.org/10.1001/jama.2017.0807 https://doi.org/10.1001/jama.2017.6803 https://doi.org/10.1001/jama.2017.3439 https://doi.org/10.1001/jama.2016.19438 https://doi.org/10.1001/jama.2016.20325 [DOI:10.1001/jama.2017.1462] [PMID]

2. Nirupama R, Divyashree S, Janhavi P, Muthukumar SP, Ravindra PV. Preeclampsia: Pathophysiology and management. J Gynecol Obstet Hum Reprod 2021; 50: 101975. [DOI:10.1016/j.jogoh.2020.101975] [PMID]

3. Nikolov A, Popovski N. Role of gelatinases MMP-2 and MMP-9 in healthy and complicated pregnancy and their future potential as preeclampsia biomarkers. Diagnostics (Basel) 2021; 11: 480. [DOI:10.3390/diagnostics11030480] [PMID] [PMCID]

4. Kornacki J, Olejniczak O, Sibiak R, Gutaj P, Wender-Ożegowska E. Pathophysiology of pre-eclampsia-two theories of the development of the disease. Int J Mol Sci 2023; 25: 307. [DOI:10.3390/ijms25010307] [PMID] [PMCID]

5. Chaiworapongsa T, Chaemsaithong P, Yeo L, Romero R. Pre-eclampsia part 1: Current understanding of its pathophysiology. Nat Rev Nephrol 2014; 10: 466-480. [DOI:10.1038/nrneph.2014.102] [PMID] [PMCID]

6. Teimoori B, Moradi-Shahrebabak M, Razavi M, Rezaei M, Harati-Sadegh M, Salimi S. The effect of GPx-1 rs1050450 and MnSOD rs4880 polymorphisms on PE susceptibility: A case-control study. Mol Biol Rep 2019; 46: 6099-6104. [DOI:10.1007/s11033-019-05045-6] [PMID]

7. Salimi S, Mohammadpour-Gharehbagh A, Hedayat M, Galavi H, Harati-Sadegh M. The effect of RNLS gene polymorphisms on preeclampsia susceptibility: A meta-analysis study. Per Med 2024; 21: 191-204. [DOI:10.1080/17410541.2024.2341608] [PMID]

8. Harati‐Sadegh M, Kohan L, Teimoori B, Mehrabani M, Salimi S. The effects of placental long noncoding RNA H19 polymorphisms and promoter methylation on H19 expression in association with preeclampsia susceptibility. IUBMB Life 2020; 72: 413-425. [DOI:10.1002/iub.2199] [PMID]

9. Mrozikiewicz AE, Kurzawińska G, Goździewicz-Szpera A, Potograbski M, Ożarowski M, Karpiński TM, et al. Effects of TIMP1 rs4898 gene polymorphism on early-onset preeclampsia development and placenta weight. Diagnostics (Basel) 2022; 12: 1637. [DOI:10.3390/diagnostics12071637] [PMID] [PMCID]

10. Cui N, Hu M, Khalil RA. Biochemical and biological attributes of matrix metalloproteinases. Prog Mol Biol Transl Sci 2017; 147: 1-73. [DOI:10.1016/bs.pmbts.2017.02.005] [PMID] [PMCID]

11. Espino SEY, Flores-Pliego A, Espejel-Nuñez A, Medina-Bastidas D, Vadillo-Ortega F, Zaga-Clavellina V, et al. New insights into the role of matrix metalloproteinases in preeclampsia. Int J Mol Sci 2017; 18: 1448. [DOI:10.3390/ijms18071448] [PMID] [PMCID]

12. Chen J, Khalil RA. Matrix metalloproteinases in normal pregnancy and preeclampsia. Prog Mol Biol Transl Sci 2017; 148: 87-165. [DOI:10.1016/bs.pmbts.2017.04.001] [PMID] [PMCID]

13. Laskowska M. Altered maternal serum matrix metalloproteinases MMP-2, MMP-3, MMP-9, and MMP-13 in severe early- and late-onset preeclampsia. Biomed Res Int 2017; 2017: 6432426. [DOI:10.1155/2017/6432426] [PMID] [PMCID]

14. Ibrahem MA, Ibrahim MM, Al-Karamany AS, Etewa RL. Gene polymorphisms and risk of preeclampsia in Egyptian women. Evid Based Women's Health J 2020; 10: 273-283.

15. Etesami E, Nikukar H, Ramezanali F, Ghotbizadeh Vahdani F, Shahhoseini M, Favaedi R, et al. Gene expression analysis of MMPs in women with preeclampsia using cell-free fetal RNA in maternal plasma. Pregnancy Hypertens 2019; 17: 261-268. [DOI:10.1016/j.preghy.2019.06.008] [PMID]

16. Jiang Y, Liu H, Wang Y, Shi X, Shao Y, Xu Z. Meta-analysis of matrix metalloproteinase (MMP)-9 C1562T polymorphism and susceptibility to ischemic stroke in the Chinese population. J Int Med Res 2020; 48: 300060520926427. [DOI:10.1177/0300060520926427] [PMID] [PMCID]

17. Meng H, Qi M, Liu Y, Xu L, Li Q. Research on correlation between MMP-9 and early-onset preeclampsia. Int J Clin Exp Med 2016; 9: 17442-17448.

18. Poon LCY, Nekrasova E, Anastassopoulos P, Livanos P, Nicolaides KH. First-trimester maternal serum matrix metalloproteinase-9 (MMP-9) and adverse pregnancy outcome. Prenat Diagn 2009; 29: 553-559. [DOI:10.1002/pd.2234] [PMID]

19. Galewska Z, Romanowicz L, Jaworski S, Bańkowski E. Gelatinase matrix metalloproteinase (MMP)-2 and MMP-9 of the umbilical cord blood in preeclampsia. Clin Chem Lab Med 2008; 46: 517-522. [DOI:10.1515/CCLM.2008.083] [PMID]

20. Buraczynska M, Wrzos S, Zaluska W. MMP9 gene polymorphism (rs3918242) increases the risk of cardiovascular disease in type 2 diabetes patients. J Clin Med 2023; 12: 6990. [DOI:10.3390/jcm12226990] [PMID] [PMCID]

21. Wang Y, Zhang L, Huang H, Qin X, Huang Z, Lan J, et al. Relationship between the matrix metalloproteinase-9 gene polymorphisms and ischemic stroke. Int J Clin Exp Pathol 2019; 12: 949-956.

22. Wadowska K, Błasiak P, Rzechonek A, Śliwińska-Mossoń M. Analysis of MMP-2-735C/T (rs2285053) and MMP-9-1562C/T (rs3918242) polymorphisms in the risk assessment of developing lung cancer. Int J Mol Sci 2023; 24: 10576. [DOI:10.3390/ijms241310576] [PMID] [PMCID]

23. Liao C-H, Tsai C-L, Chang S-Y, Lin Y-H, Wang Y-C, Huang W-C, et al. Impacts of matrix metalloproteinase 9 genotypes on renal cell carcinoma. In Vivo 2023; 37: 2452-2458. [DOI:10.21873/invivo.13351] [PMID] [PMCID]

24. Gannoun MBA, Raguema N, Zitouni H, Mehdi M, Seda O, Mahjoub T, et al. MMP-2 and MMP-9 polymorphisms and preeclampsia risk in tunisian arabs: A case-control study. J Clin Med 2021; 10: 2647. [DOI:10.3390/jcm10122647] [PMID] [PMCID]

25. Sun C, Zhang Q, Hu B, Zhang K. Investigation of the association between matrix metalloproteinase-9 genetic polymorphisms and development of pre-eclampsia in Chinese pregnant women. Gen Mol Res 2016; 15: 1-6. [DOI:10.4238/gmr.15038355] [PMID]

26. Coolman M, de Maat M, Van Heerde WL, Felida L, Schoormans S, Steegers EAP, et al. Matrix metalloproteinase-9 gene -1562C/T polymorphism mitigates preeclampsia. Placenta 2007; 28: 709-713. [DOI:10.1016/j.placenta.2006.06.017] [PMID]

27. Fraser R, Walker JJ, Ekbote UV, Martin KL, McShane P, Orsi NM. Interleukin-4 -590 (C>T), toll-like receptor-2 +2258 (G>A) and matrix metalloproteinase-9 -1562 (C>T) polymorphisms in pre-eclampsia. BJOG 2008; 115: 1052-1056. [DOI:10.1111/j.1471-0528.2008.01771.x] [PMID]

28. Palei ACT, Sandrim VC, Amaral LM, Machado JSR, Cavalli RC, Lacchini R, et al. Matrix metalloproteinase-9 polymorphisms affect plasma MMP-9 levels and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy. Pharmacogenomics J 2012; 12: 489-498. [DOI:10.1038/tpj.2011.31] [PMID]

29. Palei ACT, Sandrim VC, Duarte G, Cavalli RC, Gerlach RF, Tanus-Santos JE. Matrix metalloproteinase (MMP)-9 genotypes and haplotypes in preeclampsia and gestational hypertension. Clin Chim Acta 2010; 411: 874-877. [DOI:10.1016/j.cca.2010.03.002] [PMID]

30. Luizon MR, Sandrim VC, Palei AC, Lacchini R, Cavalli RC, Duarte G, et al. Epistasis among eNOS, MMP-9 and VEGF maternal genotypes in hypertensive disorders of pregnancy. Hypertens Res 2012; 35: 917-921. [DOI:10.1038/hr.2012.60] [PMID]

31. Leonardo DP, Albuquerque DM, Lanaro C, Baptista LC, Cecatti JG, Surita FG, et al. Association of nitric oxide synthase and matrix metalloprotease single nucleotide polymorphisms with preeclampsia and its complications. PloS One 2015; 10: e0136693. [DOI:10.1371/journal.pone.0136693] [PMID] [PMCID]

32. Rahimi Z, Rahimi Z, Omidi Shahsavandi M, Bidoki K, Rezaei M. MMP-9 (-1562 C:T) polymorphism as a biomarker of susceptibility to severe pre-eclampsia. Biomarkers Med 2013; 7: 93-98. [DOI:10.2217/bmm.12.95] [PMID]

33. Sahmani M, Ahmadi N, Asadian S, Dabaghi Ghaleh T, Javadi A. Relationship between rs3918242 polymorphism of matrix methaloproteinase-9 gene and preeclampsia in pregnant women. J Inflammat Dis 2020; 24: 434-443. [DOI:10.32598/JQUMS.24.5.6]

34. Sakowicz A, Lisowska M, Biesiada L, Rybak-Krzyszkowska M, Gach A, Sakowicz B, et al. Association of maternal and fetal single-nucleotide polymorphisms in metalloproteinase (MMP1, MMP2, MMP3, and MMP9) genes with preeclampsia. Dis Markers 2018; 2018: 1371425. [DOI:10.1155/2018/1371425] [PMID] [PMCID]

35. Abdulhafeez NA, Abd-Elgawad ER, Morad AWA, El-Shimi OS, Khashaba RA. Matrix metalloproteinase-9 gene variants and pregnancy-induced hypertension in Egyptian women: A lack of association. Benha Med J 2018; 35: 363-368. [DOI:10.4103/bmfj.bmfj_91_18]

36. Gong L-L, Liu H, Liu L-H. Lack of association between matrix metalloproteinase-9 gene-1562C/T polymorphism and preeclampsia: A meta-analysis. Hypertens Pregnancy 2014; 33: 389-394. [DOI:10.3109/10641955.2014.915033] [PMID]

37. Wang CM, Zhang SL. Non-association of MMP-9 -1562C/T polymorphism with preeclampsia risk: Evidence from a meta-analysis. Clin Exp Obstet Gynecol 2015; 42: 730-735. [DOI:10.12891/ceog2010.2015]

38. Barišić A, Dević Pavlić S, Ostojić S, Pereza N. Matrix metalloproteinase and tissue inhibitors of metalloproteinases gene polymorphisms in disorders that influence fertility and pregnancy complications: A systematic review and meta-analysis. Gene 2018; 647: 48-60. [DOI:10.1016/j.gene.2018.01.010] [PMID]

39. Zhou Y, Wang R, Chen S-X, Wu L-S, Zhu J-Q. Matrix metalloproteinase 9 gene promoter region-1562 C/T single nucleotide polymorphism increases the susceptibility to hypertensive disorders of pregnancy: A meta-analysis. Clin Exp Obstet Gynecol 2021; 48: 245-252. [DOI:10.31083/j.ceog.2021.02.2265]

40. Martorell-Marugan J, Toro-Dominguez D, Alarcon-Riquelme ME, Carmona-Saez P. MetaGenyo: A web tool for meta-analysis of genetic association studies. BMC Bioinformatics 2017; 18: 563. [DOI:10.1186/s12859-017-1990-4] [PMID] [PMCID]

41. Mohammadpour-Gharehbagh A, Jahantigh D, Saravani M, Harati-Sadegh M, Maruie-Milan R, Teimoori B, et al. Impact of HOTAIR variants on preeclampsia susceptibility based on blood and placenta and in silico analysis. IUBMB Life 2019; 71: 1367-1381. [DOI:10.1002/iub.2095] [PMID]

42. Ghorbani Z, Shakiba M, Rezavand N, Rahimi Z, Vaisi-Raygani A, Rahimi Z, et al. Gene variants and haplotypes of vitamin D biosynthesis, transport, and function in preeclampsia. Hypertens Pregnancy 2021; 40: 1-8. [DOI:10.1080/10641955.2020.1849274] [PMID]

43. Huang G, Wang Y, Qin L, Huang B, Yu X. Association and functional analysis of angiotensin-converting enzyme 2 genetic variants with the pathogenesis of pre-eclampsia. Front Endocrinol (Lausanne) 2022; 13: 926512. [DOI:10.3389/fendo.2022.926512] [PMID] [PMCID]